|
Health Affairs, 28, no. 5 (2009):
w969-w977
(Published online 25 August 2009)
doi: 10.1377/hlthaff.28.5.w969
© 2009 by Project HOPE
|
|
 |
|
|
|
Global Drug Discovery: Europe Is Ahead
Donald W. Light
It is widely believed that the United States has eclipsed Europe in pharmaceutical research productivity. Some leading analysts claim that although fewer drugs have been discovered worldwide over the past decade, most are therapeutically important. Yet a comprehensive data set of all new chemical entities approved between 1982 and 2003 shows that the United States never overtook Europe in research productivity, and that Europe in fact is pulling ahead of U.S. productivity. Other large studies show that most new drugs add few if any clinical benefits over previously discovered drugs. I discuss ways in which Congress, employers, and insurers can increase the value of drugs and revitalize the U.S. pharmaceutical industry.

What's this?
Related Articles
- Tahir Amin, Rahul Rajkumar, Priti Radhakrishnan, and Aaron S. Kesselheim
Expert Review Of Drug Patent Applications: Improving Health In The Developing World
Health Affairs,
September/October
2009; 28(5):
w948-w956.
[Abstract]
[Full Text]
[PDF]
[Table Of Contents]
- Ellen R. Shaffer and Joseph E. Brenner
A Trade Agreements Impact On Access To Generic Drugs
Health Affairs,
September/October
2009; 28(5):
w957-w968.
[Abstract]
[Full Text]
[PDF]
[Appendix]
Comments:
Read all Comments
- Global Drug Discovery Report Paints Misleading Picture
- Ken Johnson
- Health Affairs, 26 Aug 2009
[Full text]
- Global Drug Discovery: Comparing Apples To Apples
- Jerry Norris
- Health Affairs, 26 Aug 2009
[Full text]
- Questionable Assessment Of R&D Productivity
- Yann Gaston-Mathé
- Health Affairs, 27 Aug 2009
[Full text]
- Light Paints Distored Picture of U.S. Pharmaceutical R&D Efforts
- Lori M. Reilly, et al.
- Health Affairs, 25 Sep 2009
[Full text]
|